Quoin Pharmaceuticals (QNRX)

• Market cap: $3.13M
• 1 day: 2.17%
• 5 days: -7.29%
• 1 month: 23.06%
• 3 months: 24.06%
• 6 months: -20.08%
• Year to date: -87.19%
• 1 year: -85.41%
• 5 years: -99.97%
• 10 years: -99.97%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Employees: 4

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

2.01% less ownership

Funds ownership: 5.53% [Q2] → 3.52% (-2.01%) [Q3]

40% less funds holding

Funds holding: 10 [Q2] → 6 (-4) [Q3]

46% less capital invested

Capital invested by funds: $128K [Q2] → $69.2K (-$58.4K) [Q3]

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5